Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from NIDDK examining whether vitamin C influences red blood cell fragility in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Type 2 | Phase 1 | Status: COMPLETED